Biopharmaceutical Product Attributes and Biological Consequences Community

 View Only

Panel Discussion May 9th at 3 PM EST: In-Use Stability: Current Practices, Emerging Requirements, Expectations, Challenges and Trends -- organized by the AAPS Stability Community

  • 1.  Panel Discussion May 9th at 3 PM EST: In-Use Stability: Current Practices, Emerging Requirements, Expectations, Challenges and Trends -- organized by the AAPS Stability Community

    Community Leadership
    Posted 05-08-2024 09:46

    If interested, please join the panel discussion organized by the AAPS Stability Community.  

    Panel Discussion: In-Use Stability: Current Practices, Emerging Requirements, Expectations, Challenges and Trends

    DATE:  09 May 2024

    TIME: 

    12:00 pm to 12:50 pm PST
    2:00 pm to 2:50 pm CST
    3:00 pm to 3:50 pm EST

    Please join us for an engaging panel discussion titled: In-Use Stability: Current Practices, Emerging Requirements, Expectations, Challenges and Trends.

    The discussion will be driven by questions from community members and the audience on each of the following topics on in-use stability and panelists will share their experience and views:

    ·        Inputs into In-Use Study Design

    ·        Methods and Specifications

    ·        Study Timing and Sample Selection

    ·        Sample Handling and Exposure

    We hope you will be able to join us in the discussion on 9th May, as we participate in knowledge sharing and professional development.

    This session was organized by the AAPS Stability Community Leadership Team: Sherilyn Campie, Kim HuynhBa, Vinaya Kapoor, Lori McCaig, Dan Willingmyre and Kayla Woodlief.

    Panelists

    Vinaya Kapoor, PhD, Sr Director, Head of Regulatory Affairs CMC, Arcus Biosciences

    Danielle Leiske, PhD, Director, Pharmaceutical Development, AbCellera

    Jing Liu, PhD, Director, Business Strategy and Operation, Pfizer

    Tony Mazzeo, PhD, Associate Scientific Director, Product Development-ASO, Stability, BMS

    Nanda Subbarao, PhD, Sr Consultant, Biologics Consulting Group

    Sarah Weiser, MS, Sr Principal Scientist, Pfizer

    Moderators

    Sherilyn Campie, MS, Director, QC Stability, Coherus Bio Sciences

    Kim HuynhBa, MS, Managing Director, Pharmalytik

    Dan Willingmyre, Associate Director, Stability and Data Analytics, Vir Biotechnology Inc.

     

    MEETING INFORMATION

    No registration is necessary.

    The discussion will begin promptly at 12:00 pm PST/2:00 pm CST/3:00 pm EST.

    Link for Joining Virtual Panel Discussion

    Join Zoom Meeting

    https://temple.zoom.us/j/91403480752

    Meeting ID: 914 0348 0752

    One tap mobile

    +13092053325,,91403480752# US

    +13126266799,,91403480752# US (Chicago)



    ------------------------------
    Srivalli Telikepalli Ph.D.
    Research Chemist
    National Institute of Standards and Technology
    Gaithersburg MD
    [email protected]

    Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
    ------------------------------